Solstice Advanced Materials (SOLS) posts 2025 results, launches dividend and 2026 guidance

Rhea-AI Filing Summary

Solstice Advanced Materials Inc. reported mixed 2025 results with solid sales growth but sharply lower earnings, initiated a quarterly dividend, and issued 2026 guidance. Fourth-quarter 2025 net sales were $987 million, up 8% year over year, driven by double-digit growth in Refrigerants, Nuclear (Alternative Energy Services), and Electronic Materials. However, Q4 net income attributable to Solstice fell to $41 million from $133 million, and Adjusted Standalone EBITDA declined to $189 million, with margin compressing to 19.1% due mainly to higher costs, refrigerant mix shifts, and plant downtime.

For full-year 2025, net sales reached $3.886 billion, up 3%, while net income attributable to Solstice dropped to $237 million from $594 million, reflecting higher income tax expense tied to the spin-off and softer margins. Full-year Adjusted Standalone EBITDA was $957 million, down 4%, with a 24.6% margin. Capital expenditures rose 38% to $408 million to support long-term growth, and net leverage stood at about 1.5x based on 2025 Adjusted Standalone EBITDA. The Board declared the company’s first quarterly dividend of $0.075 per share, payable March 10, 2026 to shareowners of record on February 24, 2026. For 2026, Solstice guided to net sales of $3.9–$4.1 billion, Adjusted EBITDA of $975–$1,025 million, and Adjusted Diluted EPS of $2.45–$2.75, alongside capital spending of $400–$425 million.

Positive

• Initiation of quarterly dividend: The Board approved the company’s first quarterly cash dividend of $0.075 per share, payable March 10, 2026 to shareowners of record on February 24, 2026, signaling a commitment to returning capital to equity holders.
• Healthy balance sheet and liquidity: As of December 31, 2025, Solstice reported approximately $534 million of cash and cash equivalents, total liquidity of about $1.5 billion, and a non-GAAP net leverage ratio of 1.5x based on 2025 Adjusted Standalone EBITDA, supporting financial flexibility.
• 2026 guidance implies stable to growing earnings: For full-year 2026, Solstice guided to net sales of $3.9–$4.1 billion and Adjusted EBITDA of $975–$1,025 million, which, at the midpoint, is above 2025 Adjusted Standalone EBITDA of $957 million.
• Targeted growth investments: Capital expenditures rose 38% to $408 million in 2025 to support long-term growth initiatives, including capacity, technology, and efficiency projects in high-growth areas such as nuclear conversion and advanced materials.

Negative

• Significant decline in GAAP profitability: Full-year 2025 net income attributable to Solstice fell to $237 million from $594 million in 2024, a roughly 60% decrease, driven in part by higher income tax expense associated with the company’s separation from Honeywell.
• Margin compression despite higher sales: Adjusted Standalone EBITDA decreased to $957 million from $995 million in 2024, and margin fell 176 basis points to 24.6%, as transitory costs, refrigerant product mix shifts, and plant downtime more than offset favorable pricing and volume growth.
• Segment profitability deterioration: In Q4 2025, Refrigerants & Applied Solutions Segment Adjusted EBITDA dropped 25% year over year and segment margin decreased 1,225 basis points, while Electronic & Specialty Materials segment margin also declined, indicating broad margin pressure across the portfolio.

Insights

Equity earnings and cash flow analyst

Sales grew modestly, margins and GAAP earnings fell sharply, but cash generation, leverage and new dividend support a stable outlook.

Solstice delivered 2025 net sales of $3.886 billion, up 3%, with Q4 showing $987 million, up 8% year over year. Growth was broad-based, especially in Refrigerants, Nuclear (Alternative Energy Services), and Electronic Materials, while Healthcare Packaging and certain specialty lines declined.

Profitability weakened meaningfully. Full-year net income attributable to Solstice dropped to $237 million from $594 million, with management citing higher income tax expense related to the spin-off. Adjusted Standalone EBITDA slipped to $957 million from $995 million and margins compressed, reflecting transitory costs, product mix shifts toward low global warming potential refrigerants, and plant downtime.

Despite margin pressure, Solstice increased capital expenditures to $408 million in 2025 to fund growth projects and ended with about $534 million of cash and a non-GAAP net leverage ratio of 1.5x. The Board declared a first quarterly dividend of $0.075 per share and provided 2026 guidance for net sales of $3.9–$4.1 billion and Adjusted EBITDA of $975–$1,025 million, indicating expectations for stable to slightly improved earnings on higher investment.

FALSE000206495300020649532026-02-112026-02-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT – February 11, 2026

(Date of earliest event reported)

SOLSTICE ADVANCED MATERIALS INC.

(Exact name of Registrant as specified in its Charter)

Delaware			001-42812			33-2919563
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

115 Tabor Road
Morris Plains, New Jersey			07950
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code: (973) 370-8188

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SOLS

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 2.02     Results of Operations and Financial Condition

On February 11, 2026, Solstice Advanced Materials Inc. (the “Company”) issued a press release announcing its fourth quarter and full year 2025 earnings, which is furnished herewith as Exhibit 99.1. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 8.01     Other Events

On February 11, 2026, the Company announced that the Board of Directors declared a quarterly dividend of $0.075 per share of the Company’s common stock, payable on Tuesday, March 10, 2026 to shareowners of record of the Company’s common stock as of the close of business on Tuesday, February 24, 2026.

The press release announcing the quarterly cash dividend is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits

(d)    Exhibits

The following exhibits are filed as part of this report:

Exhibit No.						Exhibit
99.1						Solstice Advanced Materials Inc. Earnings Press Release dated February 11, 2026.
99.2						Solstice Advanced Materials Inc. Dividend Press Release dated February 11, 2026.
104						Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:

February 11, 2026

SOLSTICE ADVANCED MATERIALS INC.

By:

/s/ Brian Rudick

Brian Rudick

Senior Vice President, General Counsel

& Corporate Secretary

Solstice Advanced Materials Reports Fourth Quarter 2025 Results

•Net Sales of $987 million up 8% YoY reflecting double-digit growth in Nuclear (Alternative Energy Services), Electronic Materials, and Refrigerants

•Net Income attributable to Solstice Advanced Materials of $41 million

•Adjusted Standalone EBITDA1 of $189 million, with Adjusted Standalone EBITDA Margin1 of 19.1%

•For Full-Year 2025, Net Sales of $3.9 billion, Net Income attributable to Solstice Advanced Materials of $237 million and Adjusted Standalone EBITDA1 of $957 million with Adjusted Standalone EBITDA Margin1 of 24.6%

•Company provides Full-Year 2026 Guidance; expects Net Sales of $3.9-$4.1 billion, Adjusted EBITDA1 of $975-$1,025 million, Adjusted Diluted Earnings per Share (EPS)1,2 of $2.45-$2.75

MORRIS PLAINS, N.J., February 11, 2026 – Solstice Advanced Materials Inc. (Nasdaq: SOLS) (“Solstice” or “the Company”), a global leader in high-performance specialty materials, today reported financial results for the fourth quarter of 2025.

“I’m pleased to report Solstice’s strong fourth quarter results, with better-than-anticipated results reinforcing the value of our differentiated technology platform and product offerings,” said David Sewell, President and Chief Executive Officer. “We are seeing continued momentum and demand in our businesses aligned with key secular growth trends, such as data centers, A.I., and nuclear energy, underscoring the significant opportunity for long-term growth in the attractive end markets we serve. We are delivering on our commitment to invest in projects that will drive capacity, technology, and operating efficiency in these high-growth areas, including our announcement just yesterday regarding our efforts to expand our nuclear conversion business. In parallel, we remain focused on allocating capital with discipline, and we are pleased to begin returning capital to shareholders through a quarterly dividend announced today.”

Consolidated Financial Highlights			For The Three Months Ended December 31,
(Dollars in millions)			2025						2024						% Change
Net Sales			$	987					$	913					8%
Net Income attributable to Solstice			$	41					$	133					(69)%
Adjusted Standalone EBITDA1			$	189					$	235					(20)%
Adjusted Standalone EBITDA Margin1			19.1%						25.8%						(662) bps

Net Sales in the fourth quarter of 2025 were $987 million, an 8% increase compared to the fourth quarter of 2024, reflecting a 10% increase in Net Sales in the Refrigerants & Applied Solutions segment and a 4% increase in Net Sales in the Electronic & Specialty Materials segment. Organic Net Sales1 increased by 6% in the fourth quarter driven by favorable pricing and volume growth.

Net Income attributable to Solstice in the fourth quarter of 2025 was $41 million, compared to Net Income attributable to Solstice of $133 million in the fourth quarter of 2024. The decline was primarily driven by higher operating costs, net interest expense, and non-controlling interest, partially offset by higher Net Sales and lower income tax expense.

Adjusted Standalone EBITDA1 for the fourth quarter of 2025 was $189 million, a decrease of 20% compared to the fourth quarter of 2024. Adjusted Standalone EBITDA Margin1 for the fourth quarter of 2025 decreased 662 basis points to 19.1%. The decline was primarily driven by previously anticipated factors including transitory costs, the margin impact of the ongoing transition to low global warming potential (“LGWP”) refrigerants, and the impact of plant downtime and cost absorption, which more than offset strong top line growth.

1

			For The Year Ended December 31,
(Dollars in millions)			2025						2024						% Change
Net Sales			$	3,886					$	3,770					3%
Net Income attributable to Solstice			$	237					$	594					(60)%
Adjusted Standalone EBITDA1			$	957					$	995					(4)%
Adjusted Standalone EBITDA Margin1			24.6%						26.4%						(176) bps

Net Sales for the full year 2025 were $3.9 billion, a 3% increase compared to the full year 2024, reflecting a 3% increase in Net Sales in the Refrigerants & Applied Solutions segment and a 5% increase in Net Sales in the Electronic & Specialty Materials segment. Organic Net Sales1 increased by 2% for the full year 2025 driven by volume growth and favorable pricing in Refrigerants, demand-driven volume growth in Electronic Materials, and favorable pricing in Research & Performance Chemicals. This increase was partially offset by the impact of opportunistic Nuclear (Alternative Energy Services, or “AES”) sales that occurred in 2024 and volume declines in Healthcare Packaging.

Net Income attributable to Solstice for the full year 2025 was $237 million compared to Net Income attributable to Solstice of $594 million for the full year 2024, which includes the impact of higher income tax expense driven by frictional taxes associated with the Company’s spin-off from Honeywell.

Adjusted Standalone EBITDA1 for the full year 2025 was $957 million, a decrease of 4% compared to the full year 2024. Adjusted Standalone EBITDA Margin1 for the full year 2025 decreased 176 bps to 24.6%. The decline was primarily driven by refrigerants product mix as a result of the ongoing transition to LGWP refrigerants, which more than offset favorable pricing.

2

Financial Position

Capital Expenditures for the full year 2025 were $408 million, a 38% increase compared to the prior-year period due to planned increases in capital spending to drive long-term growth.

Adjusted Standalone EBITDA - capex1 for the full year 2025 was $549 million, a 21% decrease compared to the prior year. The decrease in Adjusted Standalone EBITDA - capex1 was primarily driven by the increase in Capital Expenditures and a decline in Adjusted Standalone EBITDA1.

As of December 31, 2025, the Company’s Total Long-Term Debt was $2.0 billion and Cash and Cash Equivalents were approximately $534 million. As a result, the Company’s Net Leverage ratio was approximately 1.5x based on full year 2025 Adjusted Standalone EBITDA2. Total liquidity was approximately $1.5 billion, including Cash and Cash Equivalents and $1.0 billion of availability through the Company’s revolving credit facility.

On February 9, 2026, the Solstice Board of Directors approved a quarterly cash dividend of $0.075 per share. The dividend is expected to be paid on March 10, 2026 to shareowners of record as of February 24, 2026.

Segment Highlights

Refrigerants & Applied Solutions (RAS)

			For The Three Months Ended December 31,
(Dollars in millions)			2025						2024						% Change
Net Sales
Refrigerants			$	367					$	307					20%
Building Solutions & Intermediates			181						190						(5)%
Alternative Energy Services			111						80						39%
Healthcare Packaging			52						69						(25)%
RAS Segment Net Sales			$	710					$	646					10%
RAS Segment Adjusted EBITDA			$	190					$	252					(25)%
RAS Segment Adjusted EBITDA Margin			26.8%						39.0%						(1,225) bps

Net Sales for the Refrigerants & Applied Solutions segment were $710 million in the fourth quarter of 2025, up 10% compared to the fourth quarter of 2024. Net Sales in Refrigerants increased 20% in the fourth quarter of 2025 compared to the fourth quarter of 2024, reflecting strong volume and pricing across the business’ product offerings. Net Sales in Nuclear (Alternative Energy Services) increased 39% in the fourth quarter of 2025 compared to the fourth quarter of 2024, reflecting both favorable pricing and increased volumes. These increases were partially offset by a 25% decline in Net Sales in Healthcare Packaging driven by anticipated customer destocking and a 5% decline in Building Solutions & Intermediates.

Segment Adjusted EBITDA for the Refrigerants & Applied Solutions segment decreased 25% in the fourth quarter of 2025 compared to the fourth quarter of 2024. Segment Adjusted EBITDA Margin for the segment decreased 1,225 basis points compared to the fourth quarter of 2024. The decrease was primarily driven by previously anticipated factors, including transitory cost items, plant under absorption in Healthcare Packaging in the quarter due to customer destocking, and stationary refrigerant product mix as a result of the near-term impact of the ongoing transition to LGWP refrigerants. These decreases were partially offset by favorable pricing and volume growth.

3

Electronic & Specialty Materials (ESM)

			For The Three Months Ended December 31,
(Dollars in millions)			2025						2024						% Change
Net Sales
Research & Performance Chemicals			$	121					$	125					(3)%
Electronic Materials			112						94						19%
Safety & Defense Solutions			43						48						(10)%
ESM Segment Net Sales			$	277					$	267					4%
ESM Segment Adjusted EBITDA			$	51					$	57					(11)%
ESM Segment Adjusted EBITDA Margin			18.4%						21.3%						(294) bps

Net Sales for the Electronic & Specialty Materials segment were $277 million in the fourth quarter of 2025, up 4% compared to the fourth quarter of 2024. Growth was primarily driven by a 19% increase in Electronic Materials attributable to volume growth driven by strong demand. This increase was partially offset by a 10% decline in Safety & Defense Solutions driven by lower volumes due to order timing, as well as a 3% decline in Research & Performance Chemicals due to lower construction related demand.

Segment Adjusted EBITDA for the Electronic & Specialty Materials segment decreased 11% in the fourth quarter of 2025 compared to the fourth quarter of 2024. Segment Adjusted EBITDA Margin for the segment decreased 294 basis points compared to the fourth quarter of 2024. The decrease was primarily driven by the impact of previously contemplated transitory cost items and expected plant downtime.

Corporate Expenses

Corporate Expenses totaled $52 million in the fourth quarter of 2025, compared to $48 million in the fourth quarter of 2024. The estimated incremental standalone cost adjustments were negligible in the fourth quarter of 2025, as compared to $26 million in the fourth quarter of 2024, as the Company’s efforts to prepare to operate independently were completed in anticipation of the October 2025 separation from Honeywell.

Income Tax Expense

Income Tax Expense was $32 million in the fourth quarter of 2025, a decrease of $10 million compared to the fourth quarter of 2024 due to lower pre-tax income.

Income Tax Expense was $362 million for the full year 2025, an increase of $170 million compared to the full year 2024, primarily driven by frictional taxes associated with the Company’s separation from Honeywell.

4

2026 Financial Outlook

Solstice is providing full-year and first quarter 2026 financial guidance.

For full-year 2026, Solstice expects the following:

•Net Sales in a range of $3.9 billion to $4.1 billion;

•Adjusted EBITDA1 in a range of $975 million to $1,025 million;

•Adjusted Diluted EPS1,2 in a range of $2.45 and $2.75; and

•Capital Expenditures in a range of $400 million to $425 million.

For the first quarter 2026, Solstice expects the following:

•Net Sales in a range of $935 million to $985 million; and

•Adjusted EBITDA1 in a range of $235 million to $245 million.

“As we move into 2026, we are confident in our ability to build on our track record of operational excellence and continue unleashing growth across the business,” said David Sewell, President and Chief Executive Officer. “We are well-positioned to deliver on our first quarter and full-year 2026 targets, and we will remain focused on driving shareholder value as we execute our strategy and position Solstice for continued long-term success.”

The Company does not provide a reconciliation of forward-looking Adjusted EBITDA (non-GAAP) or Adjusted Net Earnings per Share attributable to Solstice to GAAP net income (loss) attributable to Solstice, due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because deductions (such as repositioning charges, impairment charges, and litigation and other matters) used to calculate projected net income (loss) vary based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and, therefore, could result in projected GAAP net income (loss) being materially less than projected Adjusted EBITDA (non-GAAP). These statements represent forward-looking information and a projected financial outlook, and actual results may vary. Please see the risks and assumptions referred to in the “Forward-Looking Statements” section of this news release. The guidance in this news release is only effective as of the date it is given and will not be updated or affirmed unless and until the Company publicly announces updated or affirmed guidance.

1 This is a non-GAAP measure or a non-GAAP ratio. For further information on non-GAAP measures and non-GAAP ratios, please refer to the "Non-GAAP Financial Measures" section of this news release. Please also refer to tables at the end of this news release for a reconciliation of historical non-GAAP measures and ratios to the most directly comparable GAAP measure.

2 The Company defines Adjusted Diluted EPS as adjusted net income divided by the diluted weighted average shares outstanding. The Company defines Adjusted Net Income as net income attributable to Solstice Advanced Materials excluding the after-tax impact of amortization of acquired intangibles, remeasurement of foreign currencies, nonoperating pension and other postretirement expense (income), transaction-related costs, repositioning charges, asset retirement obligations accretion, asset impairment charges, litigation costs and insurance settlements (net of recoveries), gains and losses on disposal of assets, and certain other items that are otherwise of an unusual or non-recurring nature.

5

Conference Call Details

Solstice will discuss its fourth quarter results during an investor conference call starting at 8:30 a.m. Eastern Time today. A live webcast of the investor call as well as related presentation materials will be available on the Investor Relations section of the Company’s website, investor.solstice.com. The teleconference can be accessed by dialing 877-407-8029 (North America toll-free) or +1 201-689-8029 (international).

A replay of the webcast will be available shortly after the call concludes and will be available for 30 days following the presentation.

About Solstice Advanced Materials

Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications, including refrigerants, semiconductor manufacturing, data center cooling, nuclear power, protective fibers, healthcare packaging and more. Solstice is recognized for developing next-generation materials through some of the industry's most renowned brands such as Solstice®, Genetron®, Aclar®, Spectra®, Fluka™ and Hydranal™. Partnering with over 3,000 customers across more than 120 countries and territories and supported by a robust portfolio of over 5,700 patents and pending applications, Solstice’s approximately 4,000 employees worldwide drive innovation in materials science. For more information, visit www.Solstice.com.

Forward-Looking Statements

This news release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and our business and financial results. Forward-looking statements often include words such as “anticipates,” “estimates,” “expects,” “positioned,” “projects,” “forecasts,” “intends,” “plans,” “continues,” “could,” “believes,” “may,” “will,” “would,” “should,” “goals” and words and terms of similar substance in connection with discussions of future operating or financial performance. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. Our actual results may vary materially from those expressed or implied in our forward-looking statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by us or on our behalf. Although we believe that the forward-looking statements contained in this report are based on reasonable assumptions, you should be aware that a variety of factors, many of which are difficult to predict and outside of our control, could affect our actual financial results or results of operations and could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: our lack of operating history as an independent, publicly traded company and unreliability of historical consolidated financial information as an indicator of our future results; our ability to successfully develop new technologies and introduce new products; an overall decline in the health of the economy and the industries in which we operate, including as a result of inflation, tariffs and other trade barriers and restrictions, market volatility, geopolitical instability, the possibility of an economic downturn or recession or other macroeconomic factors; changes in the price and availability of raw materials that we use to produce our products, including due to factors such as supply chain disruptions and the impact of inflation; our ability to comply with complex government regulations and the impact of changes in such regulations; global climate change and related regulations and changes in customer demand; the public and political perceptions of nuclear energy and radioactive materials; economic, political, regulatory, foreign exchange and other risks of international operations; the impact of tariffs or other restrictions on foreign imports; our ability to borrow funds and access capital markets and any limitations in the terms of our indebtedness; our ability to compete successfully in the markets in which we operate; the effect on our revenue and cash flow from seasonal fluctuations and cyclical market conditions; concentrations of our credit, counterparty and market risk; our ability to successfully execute or effectively integrate potential acquisitions or complete potential divestitures; our joint ventures and strategic co-development partnerships; our ability to recruit and retain qualified personnel; potential material environmental liabilities; the hazardous nature of chemical manufacturing;

6

decommissioning and remediation expenses and regulatory requirements; potential material litigation matters, including disputes related to the Spin-off (as defined herein); the impact of potential cybersecurity attacks, data privacy breaches and other operational disruptions; increasing stakeholder interest in public company performance, disclosure, and goal-setting with respect to sustainability matters; failure to maintain, protect and enforce our intellectual property or to be successful in litigation related to our intellectual property or the intellectual property of others, or competitors developing similar or superior intellectual property or technology; unforeseen U.S. federal income tax and foreign tax liabilities and our ability to achieve anticipated tax treatments in connection with the Spin-off; U.S. federal income tax reform; our ability to operate as an independent, publicly traded company without certain benefits available to us as a part of Honeywell International Inc. (“Honeywell”), including managing the costs of operating as an independent company following the Spin-off; our ability to achieve some or all of the benefits that we expect to achieve from the Spin-off; our inability to maintain intellectual property agreements; potential timing, declaration, amount and payment of any dividend program the Company may adopt; potential cash contributions to benefit pension plans; and our ability to maintain proper and effective internal controls.

These and other factors are more fully discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections included in our final Information Statement, dated as of October 17, 2025, attached as Exhibit 99.1 to our Current Report on Form 8-K filed with the SEC on October 17, 2025, as may be updated from time to time in our SEC filings. These risks could cause actual results to differ materially from those implied by forward-looking statements in this release. Even if our results of operations, financial condition and liquidity and the development of the industry in which we operate are consistent with the forward-looking statements contained in this release, those results or developments may not be indicative of results or developments in subsequent periods.

Contacts:
Investor Relations			Media
Mike Leithead			Amy Schneiderman
(973) 370-8188			(201) 218-2302
Michael.Leithead@solstice.com			Amy.Schneiderman@teneo.com

7

SOLSTICE ADVANCED MATERIALS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)

			For The Three Months Ended December 31,												For The Year Ended December 31,
			2025						2024						2025						2024
Product sales			$	900					$	832					$	3,587					$	3,453
Service sales			87						81						299						317
Net sales			987						913						3,886						3,770
Costs, expenses and other
Cost of products sold			674						540						2,419						2,214
Cost of services sold			55						68						217						250
Total cost of products and services sold			729						608						2,636						2,464
Research and development expenses			27						21						97						83
Selling, general and administrative expenses			112						89						421						392
Transaction-related costs			27						20						117						26
Other expense (income)			(17)						(3)						(60)						(5)
Interest and other financial charges			23						2						28						13
Total costs, expenses and other			901						737						3,239						2,973
Income before taxes			86						176						647						797
Income tax expense			32						42						362						192
Net income			54						134						285						605
Less: Net income attributable to noncontrolling interest			13						1						48						11
Net income attributable to Solstice Advanced Materials			$	41					$	133					$	237					$	594
Basic earnings per share			$	0.26					$	0.84					$	1.49					$	3.74
Diluted earnings per share			$	0.26					$	0.84					$	1.49					$	3.74
Weighted average number of common shares outstanding - basic			158.7						158.7						158.7						158.7
Weighted average number of common shares outstanding -diluted			158.9						158.7						158.9						158.7

8

SOLSTICE ADVANCED MATERIALS INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(DOLLARS IN MILLIONS, EXCEPT SHARE AND PER SHARE AMOUNTS)

			December 31,
			2025						2024
ASSETS
Current assets:
Cash and cash equivalents			$	534					$	661
Accounts receivable, less allowances of $10 and $7, respectively			645						569
Inventories			715						558
Product loans receivable, current			300						—
Other current assets			193						73
Total current assets			2,388						1,861
Property, plant and equipment – net			2,055						1,746
Goodwill			820						806
Intangible assets – net			49						35
Deferred income taxes			6						3
Product loans receivable, noncurrent			—						264
Investments			162						146
Other noncurrent assets			192						142
Total assets			$	5,673					$	5,004
LIABILITIES
Current liabilities:
Accounts payable			$	909					$	778
Current portion of long-term debt			4						—
Product loans payable, current			320						—
Finance lease liabilities, current			14						22
Accrued liabilities and other current liabilities			467						283
Total current liabilities			1,713						1,083
Long-term debt			1,968						—
Deferred income taxes			233						179
Product loans payable, noncurrent			16						293
Finance lease liabilities, noncurrent			104						37
Other noncurrent liabilities			262						230
Total liabilities			4,296						1,822
Commitments and Contingencies
EQUITY
Common stock (par value $0.01 per share; 500,000,000 shares authorized; 158,747,196 shares issued and outstanding at December 31, 2025; 0 shares issued and outstanding at December 31, 2024)			2						—
Additional paid-in capital			1,495						—
Net Parent investment			—						3,471
Accumulated other comprehensive loss			(127)						(213)
Retained earnings			41						—
Total Solstice Advanced Materials stockholders’ equity			1,411						3,258
Noncontrolling interest			(34)						(76)
Total equity			1,377						3,182
Total liabilities and equity			$	5,673					$	5,004

9

Non-GAAP Financial Measures

The Company uses non-GAAP financial measures to supplement the financial measures prepared in accordance with U.S. GAAP. These include (1) Organic sales percentage, (2) Adjusted EBITDA, (3) Adjusted EBITDA Margin, (4) Adjusted Standalone EBITDA, (5) Adjusted Standalone EBITDA margin, (6) Adjusted Standalone EBITDA - capex, (7) Cash conversion, (8) Net debt, (9) Total leverage ratio, and (10) Net leverage ratio.

Below are definitions and reconciliations of certain non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP. Management believes that, when considered together with reported amounts, these measures are useful to investors and management in understanding our ongoing operations and in the analysis of ongoing operating trends. Management believes these non-GAAP financial measures provide investors with a meaningful measure of its performance period to period, align the measures to how management evaluates performance internally, and make it easier for investors to compare our performance to peers. These measures should be considered in addition to, and not as replacements for, the most directly comparable U.S. GAAP measure. The non-GAAP financial measures we use are as follows:

•Organic sales percentage: The Company defines organic sales percentage as the year-over-year change in reported sales relative to the comparable period, excluding the impact on sales from foreign currency translation and acquisitions, net of divestitures, for the first 12 months following the transaction date. We believe this measure is useful to investors and management in understanding our ongoing operations and in analysis of ongoing operating trends.

•Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Standalone EBITDA, and Adjusted Standalone EBITDA margin: The Company defines Adjusted EBITDA as net income excluding income taxes, depreciation, amortization, interest and other financial charges, remeasurement of foreign currencies, stock-based compensation expense, pension and other postretirement expense (income), transaction-related costs, repositioning charges, asset retirement obligations accretion, asset impairment charges, litigation costs and insurance settlements (net of recoveries), gains and losses on disposal of assets, and certain other items that are otherwise of an unusual or non-recurring nature. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by Net sales. The Company defines Adjusted Standalone EBITDA as Adjusted EBITDA less estimated recurring and ongoing costs required to operate a new independent public company, and autonomous entity adjustments as well as adjustments for certain other employee compensation expense for employees that have historically been shared with other Honeywell businesses and were transferred to the Company in connection with the spin-off. The Company defines Adjusted Standalone EBITDA Margin as Adjusted Standalone EBITDA divided by Net sales. We believe these measures are useful to investors as they provide greater transparency with respect to supplemental information used by management in its financial and operational decision making, as well as understanding ongoing operating trends.

•Adjusted Standalone EBITDA – capex, and Cash Conversion: The Company defines Adjusted Standalone EBITDA - capex as Adjusted Standalone EBITDA less capital expenditures. Capital expenditures represent capital expenditures incurred, whether accrued or paid in the current year. The Company defines cash conversion as Adjusted Standalone EBITDA - capex divided by Adjusted Standalone EBITDA. We believe these measures are useful to investors and management as a measure of cash generated by operations that can be used to invest in future growth through new business development activities or acquisitions, pay dividends, repurchase stock, or repay debt obligations prior to their maturities. These measures can also be used to evaluate our ability to generate cash flow from operations and the impact that this cash flow has on our liquidity.

•Net debt, total leverage ratio and net leverage ratio: The Company defines net debt as total debt less cash. The Company defines total leverage ratio as total debt divided by Adjusted EBITDA. The Company defines net leverage ratio as net debt divided by Adjusted EBITDA. For purposes of showing total leverage ratio and net leverage ratio, we use Adjusted Standalone EBITDA instead of Adjusted EBITDA. We believe these measures are useful to investors and management in understanding our overall financial condition.

10

Organic Sales Percentage

			For The Three Months Ended December 31,									For The Year Ended December 31,
			2025 vs 2024									2025 vs 2024
Total % change in net sales			8		%							3		%
Foreign currency translation			(2)		%							(1)		%
Acquisitions, divestitures and other, net			—		%							—		%
Organic sales percentage			6		%							2		%

Adjusted EBITDA, Adjusted Standalone EBITDA, Adjusted EBITDA margin and Adjusted Standalone EBITDA margin

			For The Three Months Ended December 31,												For The Year Ended December 31,
(Dollars in millions)			2025						2024						2025						2024
Net income attributable to Solstice Advanced Materials (GAAP)			$	41					$	133					$	237					$	594
Net income attributable to noncontrolling interest			13						1						48						11
Net income (GAAP)			$	54					$	134					$	285					$	605
Depreciation			40						49						191						175
Amortization			14						7						29						42
Interest and other financial charges			23						3						28						13
Other adjustments(1)			(8)						3						(38)						28
Stock compensation expense			8						4						27						17
Transaction-related costs			27						19						117						26
Income tax expense			32						42						362						192
Adjusted EBITDA (Non-GAAP)			$	189					$	261					$	1,000					$	1,098
Less - Standalone adjustments			—						(26)						(43)						(103)
Adjusted Standalone EBITDA (Non-GAAP)			$	189					$	235					$	957					$	995
Net Sales			$	987					$	913					$	3,886					$	3,770
Adjusted EBITDA margin (Non-GAAP)			19.1		%				28.6%						25.7		%				29.1%
Adjusted Standalone EBITDA Margin (Non-GAAP)			19.1		%				25.8%						24.6		%				26.4%

_________________

1.Other adjustments primarily consisted of gains and losses from disposal of long-lived assets, remeasurement of foreign currencies, environmental reserves, asset retirement obligations, pensions expenses, and certain legal costs, net of recoveries.

11

Adjusted Standalone EBITDA – capex and Cash Conversion

									For The Year Ended December 31,
(Dollars in millions)															2025						2024
Adjusted Standalone EBITDA (Non-GAAP)															$	957					$	995
Less: capital expenditures															(408)						(296)
Adjusted Standalone EBITDA - capex (Non-GAAP)															$	549					$	699
Cash conversion (Non-GAAP)															57.4%						70.3%

Net debt, total leverage ratio and net leverage ratio as of December 31, 2025

(Dollars in millions)
Total Debt			$	1,972
Less: Cash and Cash Equivalents			(534)
Net Debt (Non-GAAP)			$	1,438
Adjusted Standalone EBITDA (Non-GAAP)			$	957
Total Leverage Ratio (Non-GAAP)			2.1		x
Net Leverage Ratio (Non-GAAP)			1.5		x

Reconciliation of Segment Adjusted EBITDA to Adjusted Standalone EBITDA

			For The Three Months Ended December 31,												For The Year Ended December 31,
(Dollars in millions)			2025						2024						2025						2024
RAS Segment Adjusted EBITDA			$	190					$	252					$	981					$	1,058
ESM Segment Adjusted EBITDA			51						57						203						201
Segment Adjusted EBITDA			$	241					$	309					$	1,184					$	1,259
Less:
Corporate and All Other			(52)						(48)						(184)						(161)
Standalone Adjustments			—						(26)						(43)						(103)
Adjusted Standalone EBITDA (Non-GAAP)			$	189					$	235					$	957					$	995

12

Solstice Advanced Materials Announces First Shareowner Dividend

MORRIS PLAINS, N.J., February 11, 2026 – Solstice Advanced Materials (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced that its Board of Directors has declared a quarterly dividend payment of seven and a half cents ($0.075) per share of its common stock. The dividend will be payable on March 10, 2026, to shareowners of record on February 24, 2026.

“Today’s announcement reflects our strong early performance as an independent company and our commitment to return capital to shareowners,” said Solstice President and CEO David Sewell. “We continue to focus on advancing science to support our customers and their end markets with leading high-performance specialty materials and chemicals solutions.”

About Solstice Advanced Materials 
Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications, including refrigerants, semiconductor manufacturing, data center cooling, nuclear power, protective fibers, healthcare packaging and more. Solstice is recognized for developing next-generation materials through some of the industry's most renowned brands such as Solstice®, Genetron®, Aclar®, Spectra®, Fluka™ and Hydranal™. Partnering with over 3,000 customers across more than 120 countries and territories and supported by a robust portfolio of over 5,700 patents and pending applications, Solstice’s approximately 4,000 employees worldwide drive innovation in materials science.

For more information, visit www.Solstice.com. 

Forward-Looking Statements

This news release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, ongoing macroeconomic and geopolitical risks, such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, and inflation, that can affect Solstice’s performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this release can or will be achieved. These forward-looking statements should be considered in light of the information included in this release, Solstice’s final information statement, dated October 17, 2025, and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. Solstice does not undertake to update or revise any of its forward-looking statements, which speak only as of the date they are made.

Contacts:

Investor Relations			Media
Mike Leithead			Amy Schneiderman
(973) 370-8188			(201) 218-2302
Michael.Leithead@solstice.com			Amy.Schneiderman@teneo.com

FAQ

How did Solstice Advanced Materials (SOLS) perform financially in full-year 2025?

Solstice generated net sales of $3.886 billion in 2025, up 3% from 2024, reflecting growth in Refrigerants and Electronic Materials. Net income attributable to Solstice was $237 million, down sharply from $594 million, as higher income taxes and margin pressure outweighed modest revenue gains.

What were Solstice Advanced Materials’ (SOLS) key fourth-quarter 2025 results?

In Q4 2025, Solstice reported net sales of $987 million, an 8% year-over-year increase, led by Refrigerants, Nuclear services, and Electronic Materials. Net income attributable to Solstice was $41 million, down from $133 million, and Adjusted Standalone EBITDA declined to $189 million with a 19.1% margin.

What 2026 financial guidance did Solstice Advanced Materials (SOLS) provide?

For full-year 2026, Solstice expects net sales of $3.9–$4.1 billion and Adjusted EBITDA of $975–$1,025 million. The company also guides to Adjusted Diluted EPS of $2.45–$2.75 and capital expenditures between $400 million and $425 million, reflecting continued investment.

Did Solstice Advanced Materials (SOLS) announce a dividend, and what are the details?

Yes. Solstice’s Board declared a quarterly dividend of $0.075 per share of common stock. The dividend will be payable on March 10, 2026 to shareowners of record as of February 24, 2026, marking the company’s first regular cash dividend to shareholders.

How strong is Solstice Advanced Materials’ (SOLS) balance sheet and leverage profile?

As of December 31, 2025, Solstice held $534 million of cash and cash equivalents and total long-term debt of about $2.0 billion. Management reported a net leverage ratio of approximately 1.5x based on 2025 Adjusted Standalone EBITDA, with total liquidity near $1.5 billion.

What were the main drivers of Solstice Advanced Materials’ margin and earnings decline in 2025?

Solstice cited higher income tax expense related to its spin-off from Honeywell, transitory cost items, plant downtime, and product mix shifts toward low global warming potential refrigerants as key factors. These pressures reduced Adjusted Standalone EBITDA and compressed margins despite revenue growth.

How did Solstice Advanced Materials’ (SOLS) business segments perform in Q4 2025?

In Q4 2025, Refrigerants & Applied Solutions segment net sales rose to $710 million, up 10%, but segment Adjusted EBITDA fell 25%. Electronic & Specialty Materials segment net sales increased 4% to $277 million, while segment Adjusted EBITDA declined 11%, reflecting cost and mix headwinds.

Filing Exhibits & Attachments

5 documents

Press Releases

• EX-99.1 EX-99.1 274.8 KB
• EX-99.2 EX-99.2 9.0 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.1 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB